Clinical Trials Data Partnership Joins Verily with Pharma Giants

Verily Life Sciences, the healthcare subsidiary of Google parent Alphabet, said today it will partner with four pharma giants—Novartis, Otsuka Pharmaceutical, Pfizer, and Sanofi—to...
Abstract DNA.

Panel Identifies Hurdles to Wider AI Use in Diagnostic, Rx Development

Artificial intelligence (AI) is gaining a foothold in the discovery and development of drugs and diagnostics—but its use in both will remain limited unless companies surmount hurdles to the technology in the next few years, a panel of industry executives agreed.
Business Team Discussion Meeting Corporate Success Concept

Congenica Raises Additional £13.25 in Series B Financing Round

Clinical decision support platform provider Congenica,  announced it has raised a further £13.25 million ($17.2 million) in additional equity investment, led by Parkwalk Advisors....

Rady Researchers Use AI ‘Pipeline’ for Rapid Diagnosis of Rare Genetic Diseases

Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) have built an automated pipeline designed to deliver a potential diagnosis in record time for hospitalized...

Genomenon, Parabricks Offer Products Via Google Cloud Platform

A pair of companies specializing in applying computing to genomics said today they will make their products available via Google Cloud Platform, through partnerships...

DNAnexus, UPMC, Sutter Health Launch Clinico-Genomic MS Precision Medicine Study

Clinico-genomic research study aims to improve personalized treatments for people with multiple sclerosis
Blocked blood vessel 3D render

AI IDs Potentially Life-Threatening Genetic Disease Using EHRs

The classifier could help to flag patients who are most likely to have familial hypercholesterolemia, so that they and their families can undergo further genetic testing.

Flatiron Health, Foundation Medicine Publish Study Validating Clinico-Genomic Database

The study validates that real-world data obtained from routine clinical care to create a multi-institution clinico-genomic database can yield clinically meaningful insights.
Biotechnology, conceptual illustration

Concerto HealthAI Enters Precision Oncology Collaboration with Pfizer

Concerto HealthAI announced today the company entered a precision oncology collaboration with Pfizer using Concerto HealthAI’s eurekaHealth platform, artificial intelligence (AI) models and data...

Lack of Diverse Ancestry Data Hinders Polygenic Risk Scores

A new study shows PRSs developed by studying Europeans do a better job at predicting disease risk for people of European ancestry than for those of other ancestries
Scroll Up